Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA
Authors:
- Jinyong HuangJHJinyong Huang
- Alex C. SoupirASAlex C. Soupir
- Brian D. SchlickBSBrian D. Schlick
- Mingxiang TengMTMingxiang Teng
- Ibrahim H. SahinISIbrahim H. Sahin
- Jennifer B. PermuthJPJennifer B. Permuth
- Erin M. SiegelESErin M. Siegel
- Brandon J. ManleyBMBrandon J. Manley
- Bruna PelliniBruna Pellini
- Liang WangLWLiang Wang
Open Access
Abstract
Cell-free DNA (cfDNA) methylation has emerged as a promising biomarker for early cancer detection, tumor type classification, and treatment response monitoring. Enrichment-based cfDNA methylation profiling methods such as cfMeDIP-seq have shown high accuracy in the classification of multiple cancer types. We have previously optimized another enrichment-based approach for ultra-low input cfDNA methylome profiling, termed cfMBD-seq. We reported that cfMBD-seq outperforms cfMeDIP-seq in the enrichment of high-CpG-density regions, such as CpG islands. However, the clinical feasibility of cfMBD-seq is unknown. In this study, we applied cfMBD-seq to profiling the cfDNA methylome using plasma samples from cancer patients and non-cancer controls. We identified 1759, 1783, and 1548 differentially hypermethylated CpG islands (DMCGIs) in lung, colorectal, and pancreatic cancer patients, respectively. Interestingly, the vast majority of DMCGIs were overlapped with aberrant methylation changes in corresponding tumor tissues, indicating that DMCGIs detected by cfMBD-seq were mainly driven by tumor-specific DNA methylation patterns. From the overlapping DMCGIs, we carried out machine learning analyses and identified a set of discriminating methylation signatures that had robust performance in cancer detection and classification. Overall, our study demonstrates that cfMBD-seq is a powerful tool for sensitive detection of tumor-derived epigenomic signals in cfDNA.Keywords
Funding Information
- National Institute of Health (R01CA212097 and R01CA250018)
This publication has 52 references indexed in Scilit:
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome SequencingScience Translational Medicine, 2012
- Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Regulation of Immune Responses by Prostaglandin E2The Journal of Immunology, 2012
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancerBMC Medicine, 2011
- Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage biasEpigenetics, 2011
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shoresNature Genetics, 2009
- DNA methylation landscapes: provocative insights from epigenomicsNature Reviews Genetics, 2008
- Cancer epigenomics: DNA methylomes and histone-modification mapsNature Reviews Genetics, 2007